Transcatheter Cardiovascular Therapeutics (TCT)

World Congress Of Cardiology & Cardiovascular Health (World Heart Federation)

High exposure to radiofrequency radiation (RFR) in rodents resulted in tumors in tissues surrounding nerves in the hearts of male rats, but not female rats or any mice, according to draft studies from the National Toxicology Program (NTP). The exposure levels used in the studies were equal to and higher than the highest level permitted for local tissue exposure in cell phone emissions today. Cell phones typically emit lower levels of RFR than the maximum level allowed. NTP’s draft conclusions were released as two technical reports, one for rat studies and one for mouse studies. NTP will hold an external expert review of its complete findings from these rodent studies March 26-28.

Step 2/3

TEVAR Stent Grafts

February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion of enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study.


Here are several considerations for physicians when choosing endovascular stent grafts used to treat aortic aneurysms. Multiple devices are available on the market, each with unique features. 

International Conference on Prehypertension, Hypertension and Cardio Metabolic Syndrome

February 5, 2018 — Sacs of fluid in the kidneys may indicate there is also blood vessel damage in the brain and a heightened risk of stroke, according to preliminary research presented at the American Stroke Association’s International Stroke Conference 2018, Jan. 24-26 in Los Angeles.


Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2018. This is based on website analytics of the month’s 139,874 pageviews:

1. New Technologies to Improve Atrial Fibrillation Ablation


February 5, 2018 — Children's Hospital Los Angeles announced participation in the first-ever clinical trial using stem cells from umbilical cord blood to delay or even prevent heart failure in children born with a rare congenital heart defect leaving them with ha

Subscribe Now